BIOATLA INC by BioAtla, Inc. Analyst Price Targets

Wall Street analyst price targets and consensus rating for BIOATLA INC by BioAtla, Inc. (BCAB).

Price Target Range — 5 Quarters

Analyst Consensus — 3 Analysts

1S.Buy

2Hold

Consensus RatingMarket Outperform# Analysts3Avg. Consensus PT$150Upside to Avg. PT+11011.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 13, 2025	JMP Securities	Reni J. Benjamin	Downgrade	Market Outperform→Market Perform	—
Mar 31, 2025	Citizens Capital Markets	Reni Benjamin	PT Cut	Market Outperform	$5→$1
Mar 31, 2025	HC Wainwright & Co.	Arthur He	Maintained	Neutral	—
Nov 13, 2024	HC Wainwright & Co.	Arthur He	Downgrade	Buy→Neutral	—
Sep 16, 2024	JMP Securities	Reni Benjamin	Maintained	Market Outperform	$5
May 23, 2024	JMP Securities	Reni Benjamin	PT Cut	Market Outperform	$12→$5
May 15, 2024	HC Wainwright & Co.	Arthur He	Maintained	Buy	$7
Mar 28, 2024	JMP Securities	Reni Benjamin	Maintained	Market Outperform	$12
Mar 27, 2024	HC Wainwright & Co.	Arthur He	PT Cut	Buy	$10→$7
Dec 5, 2023	JMP Securities	Reni Benjamin	Maintained	Market Outperform	$12
Nov 8, 2023	HC Wainwright & Co.	Arthur He	PT Cut	Buy	$17→$10

Benzinga Newsdesk

Benzinga Newsdesk

Benzinga Newsdesk

Benzinga Newsdesk

Benzinga Newsdesk

Benzinga Newsdesk